BioTek Instruments Announces Establishment of Korean Office
News Mar 01, 2011
BioTek Korea will be fully functional by July 1, 2011. BioTek's long-time partner and distributor, DI Biotech, will work closely with BioTek Korea to ensure a seamless transition for the company's existing and expanding customer base.
"The establishment of BioTek Korea will allow BioTek to increase our investment of resources in this very important marketplace," commented Briar Alpert, BioTek President and CEO. "In addition to providing incremental local service and application support, our customers in South Korea will have direct access to the company's global scientific and applications resources. Ultimately, this will lead to enhanced customer satisfaction for our Korean customers."
Researchers have created a portable and fast-acting test that can distinguish Ebola infections from other fever-causing infectious diseases such as Lassa fever and malaria in around 30 minutes. Although further testing is required, this could be useful during febrile disease outbreaks.READ MORE